Department of Nutritional Sciences, University of Toronto, Temerty Faculty of Medicine, Ontario, Toronto, Canada.
Translational Medicine Program, The Hospital for Sick Children, Ontario, Toronto, Canada.
BMJ Open. 2022 May 9;12(5):e057989. doi: 10.1136/bmjopen-2021-057989.
The gut microbiota interacts with diet to affect body health throughout the life cycle. Critical periods of growth, such as infancy and puberty, are characterised by microbiota remodelling and changes in dietary habits. While the relationship between gut microbiota and growth in early life has been studied, our understanding of this relationship during puberty remains limited. Here, we describe the MIcrobiota, GROWth and Diet in peripubertal children (The MiGrowD) study, which aims to assess the tripartite growth-gut microbiota-diet relationship at puberty.
The MiGrowD study will be a cross-sectional, community-based study involving children 8-12 years participating in the TARGet Kids!
TARGet Kids! is a primary healthcare practice-based research network in Canada. Children will be asked to provide a stool sample, complete two non-consecutive 24-hour dietary recalls and a pubertal self-assessment based on Tanner Stages. Anthropometry will also be conducted. The primary outcome is the association between gut microbiota composition and longitudinal growth from birth until entry into the study. Anthropometrics data from birth will be from the data collected prospectively through TARGet Kids!. Body mass index z-scores will be calculated according to WHO. The secondary outcome is the association between gut microbiota, diet and pubertal stage.
Ethics approval has been obtained by the Hospital for Sick Children and St. Michael's Hospital-Unity Health, and the University of Toronto. Results will be disseminated in the public and academic sector, including participants, TARGet Kids! primary healthcare physicians teams, scientists via participation in the TARGet Kids! science and physician meetings, conferences and publications in peer-reviewed journals. The MiGrowD study results will help researchers understand the relationships underlying growth, gut microbiota and pubertal maturation in children.
肠道微生物群通过饮食相互作用,影响整个生命周期的身体健康。生长的关键时期,如婴儿期和青春期,其特点是微生物群的重塑和饮食习惯的改变。虽然肠道微生物群与生命早期的生长关系已经得到研究,但我们对青春期期间这种关系的理解仍然有限。在这里,我们描述了青春期儿童的微生物群、生长和饮食(MiGrowD)研究,该研究旨在评估青春期时三方生长-肠道微生物群-饮食关系。
MiGrowD 研究将是一项横断面、基于社区的研究,涉及 8-12 岁参加 TARGet Kids!的儿童。将要求儿童提供粪便样本,完成两次不连续的 24 小时膳食回忆和基于 Tanner 阶段的青春期自我评估。还将进行人体测量学检查。主要结局是肠道微生物群组成与从出生到进入研究的纵向生长之间的关联。出生时的人体测量学数据将来自通过 TARGet Kids!前瞻性收集的数据。体重指数 z 分数将根据世卫组织计算。次要结局是肠道微生物群、饮食和青春期阶段之间的关联。
SickKids 医院和圣迈克尔医院-统一健康中心以及多伦多大学已获得伦理批准。结果将在公众和学术界传播,包括参与者、TARGet Kids!初级保健医生团队、科学家通过参加 TARGet Kids!科学和医生会议、会议和在同行评议期刊上发表文章传播。MiGrowD 研究结果将帮助研究人员了解儿童生长、肠道微生物群和青春期成熟之间的潜在关系。